Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Relmada Therapeutics, Inc.    RLMD

RELMADA THERAPEUTICS, INC.

(RLMD)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Purcell Julie & Lefkowitz LLP Is Investigating Relmada Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

share with twitter share with LinkedIn share with facebook
share via e-mail
11/19/2019 | 04:59pm EST

NEW YORK, Nov. 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Relmada Therapeutics, Inc. (NASDAQ: RLMD).

If you are a shareholder of Relmada Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, free of charge, please visit us at:

http://pjlfirm.com/relmada-therapeutics-inc/

You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000.  One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell Julie & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit http://pjlfirm.com.   Attorney advertising. Prior results do not guarantee a similar outcome. 

Cision
View original content:http://www.prnewswire.com/news-releases/shareholder-alert-purcell-julie--lefkowitz-llp-is-investigating-relmada-therapeutics-inc-for-potential-breaches-of-fiduciary-duty-by-its-board-of-directors-300961317.html

SOURCE Purcell Julie & Lefkowitz LLP


© PRNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on RELMADA THERAPEUTICS, INC.
02/25RELMADA THERAPEUTICS : to Present at 9th Annual SVB Leerink Global Healthcare Co..
PR
01/13RELMADA THERAPEUTICS : Strengthens Financial Operations with Addition of Maged S..
AQ
01/10RELMADA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financia..
AQ
01/10RELMADA THERAPEUTICS : Strengthens Financial Operations with Addition of Maged S..
PR
2019RELMADA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Amendmen..
AQ
2019RELMADA THERAPEUTICS : Strengthens Board of Directors with Appointments of Life ..
AQ
2019RELMADA THERAPEUTICS : Strengthens Board of Directors with Appointments of Life ..
PR
2019RELMADA THERAPEUTICS : Announces Closing of $115 Million Public Offering of Comm..
PR
2019RELMADA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financi..
AQ
2019RELMADA THERAPEUTICS : Announces Pricing of Public Offering of Common Stock
PR
More news